Johnson & Johnson (JNJ)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$145.17

Buy

$145.49

arrow-up$0.80 (+0.55%)

Prices updated at 23 Dec 2024, 23:43 EST
| Prices minimum 15 mins delay
|
Prices in USD

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Timothy Schmid
CEO
Mr. Joaquin Duato
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
134,400
Head office
One Johnson and Johnson Plaza
New Brunswick
United States
08933
mobile
+1 732 524-0400
letter
investor-relations@its.jnj.com

Key personnel

Salary
Mr. Kristen Mulholland
Chief Human Resources Officer
-
Ms. Anne M. Mulcahy
Lead Independent Director
0.20m
Dr. John C. Reed,M.D.,PhD
Executive Vice President, Innovative Medicine, R&D
0.84m
Ms. Marillyn A. Hewson
Independent Director
0.15m
Dr. Paula A. Johnson,M.D.
Independent Director
0.11m
Mr. Hubert Joly
Independent Director
0.13m
Dr. Mary C. Beckerle, PhD
Independent Director
0.15m
Mr. Darius E. Adamczyk
Independent Director
0.13m
Dr. Mark B. McClellan, M.D.,PhD
Independent Director
0.13m
Mr. Joaquin Duato
Chairman of the Board and Chief Executive Officer
1.58m
Dr. Jennifer A. Doudna, PhD
Independent Director
0.13m
Mr. Joseph J. Wolk, C.P.A.
Executive Vice President and Chief Financial Officer
1.15m
Mr. James D. Swanson
Executive Vice President and Chief Information Officer
-
Ms. Jennifer L. Taubert
Executive Vice President and Worldwide Chairman, Innovative Medicine
1.13m
Ms. Kathryn E. Wengel
Executive Vice President and Chief Technical Operations & Risk Officer
-
Mr. Eugene A. Woods
Independent Director
0.01m
Dr. Nadja Y West, M.D.
Independent Director
0.13m
Mr. Mark A. Weinberger
Independent Director
0.15m
Mr. Robert J. Decker, Jr
Controller and Chief Accounting Officer
-
Mr. William N. Hait, M.D.,PhD
Executive Vice President, Chief External Innovation and Medical Officer
-
Ms. Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs
-
Ms. Elizabeth Forminard
Executive Vice President and General Counsel
-
Mr. Timothy Schmid
Executive Vice President and Worldwide Chairman, MedTech
-

Top 5 shareholders

No. of shares
Vanguard Group Inc231,019,853
BlackRock Inc198,186,824
State Street Corp134,245,811
Vanguard Investments Australia Ltd77,520,684
Vanguard US Total Market Shares ETF76,276,335

Director dealings

Action
05 Dec 2023-
07 Sep 2023-
23 Aug 2023-
23 Aug 2023-
23 Aug 2023-
23 Aug 2023-
23 Aug 2023-
26 Jul 2023-
26 Jul 2023-
26 Jul 2023-
25 Jul 2023-
12 Jun 2023-
06 Jun 2023-
24 May 2023-
27 Apr 2023-
27 Apr 2023-
27 Apr 2023-
27 Apr 2023-
27 Apr 2023-
27 Apr 2023-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.